Testagen (20 mg vial)

Protocol Overview

Concise summary of the regimen.

Dosing & Reconstitution

Frequency: Inject once daily subcutaneously. For administrations under 10 units, use 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl until dissolved (do not shake).
4. Label and refrigerate at 2 to 8 °C, protected from light. At 6.67 mg/mL, 1 unit = 0.01 mL » 66.7 mcg on a U-100 insulin syringe.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: store at -20 °C (-4 °F) in dry, dark conditions; stable for 12+ months.
• Reconstituted: refrigerate at 2 to 8 °C (35.6 to 46.4 °F); avoid freeze-thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Supplies Needed

Plan based on an 8 to 16 week daily protocol with gradual titration.

Peptide Vials (Testagen, 20 mg each):

• 8 weeks: ~1 vial (~14 mg used).
• 12 weeks: ~2 vials (~25 mg used).
• 16 weeks: ~2 vials (~36 mg used).

Insulin Syringes (U-100, 30- or 50-unit recommended):

• Per week: 7 syringes (1/day).
• 8 weeks: 56 syringes. 12 weeks: 84 syringes. 16 weeks: 112 syringes.

Bacteriostatic Water (10 mL bottles):

• Use 3.0 mL per vial.
• 8 to 16 weeks: 1 x 10 mL bottle.

Alcohol Swabs:

• 8 weeks: 112 swabs. 12 weeks: 168 swabs. 16 weeks: 224 swabs (3 x 100-count boxes).

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Due to very low injection volumes, a 30- or 50-unit syringe is recommended for precision.

How This Works

Testagen (Lys-Glu-Asp-Gly) belongs to a class of short bioregulatory peptides derived from anterior pituitary extracts. Preclinical research in avian models demonstrates this tetrapeptide can normalize thyroid hormone levels in hypophysectomized subjects and modulate endocrine signaling along the pituitary-gonadal axis. These peptides are hypothesized to act through gene-regulatory mechanisms influencing hormone synthesis and secretion. No human clinical trials exist.

Benefits & Side Effects

Observations from preclinical and clinical literature.

• Preclinical studies suggest normalization of thyroid hormone parameters in hypophysectomized models.
• Research indicates potential modulation of male reproductive hormones via pituitary pathways.
• No published human safety or efficacy data; side-effect profile in humans remains unknown.
• Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for best outcomes.

• Maintain a balanced, nutrient-dense diet supporting endocrine health.
• Engage in regular physical activity to support hormonal balance.
• Prioritize quality sleep (7 to 9 hours) to optimize endogenous hormone rhythms.
• Manage stress through mindfulness or other techniques to reduce cortisol interference.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry.
2. Pinch a skinfold; insert the needle at 45 to 90 degrees into subcutaneous tissue.
3. Do not aspirate for subcutaneous injections; inject slowly and steadily.
4. Wait 5 to 10 seconds before withdrawing; dispose of syringe in sharps container.
5. Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

References

Source citations for further reading.

1. Effects of hypophyseal Lys-Glu-Asp-Gly peptide on immunity, hemostasis, and thyroid function (PubMed).
2. Khavinson VK et al. Peptide Regulation of Gene Expression: A Systematic Review.